Page last updated: 2024-08-23

pefloxacin and Nephrosis, Lipoid

pefloxacin has been researched along with Nephrosis, Lipoid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumelou, A; Deray, G; Ginsburg, C; Jacobs, C; Toledano, D; Vlassopoulos, D1
Moulin, B1
Barka, A; Boulanger, H; Hauet, T; Landais, P; Nochy, D; Pruna, A1
Akposso, K; Bedrossian, J; Druet, P; Idatte, JM; Metivier, F; Nochy, D; Pruna, A; Saltiel, C1

Trials

1 trial(s) available for pefloxacin and Nephrosis, Lipoid

ArticleYear
[Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
    Nephrologie, 1997, Volume: 18, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Creatinine; Female; Humans; Immunoglobulins; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Pefloxacin; Pilot Projects; Predictive Value of Tests; Proteinuria; Remission Induction; Serum Albumin; Treatment Outcome

1997

Other Studies

3 other study(ies) available for pefloxacin and Nephrosis, Lipoid

ArticleYear
Pefloxacin as first-line treatment in nephrotic syndrome.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:3

    Topics: Adolescent; Adult; Female; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Pefloxacin; Proteinuria

1994
[Pefloxacin as a treatment for nephrotic syndrome caused by minimal glomerular lesions in the adult: promises or deception?].
    Nephrologie, 1997, Volume: 18, Issue:3

    Topics: Adult; Aged; Animals; Anti-Infective Agents, Urinary; Child; Cytokines; Depression, Chemical; Drug Evaluation; Female; Hemodynamics; Humans; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Pefloxacin; Placebo Effect; Rats; Remission, Spontaneous; Secretory Rate

1997
Pefloxacin as first-line treatment in nephrotic syndrome.
    Lancet (London, England), 1992, Sep-19, Volume: 340, Issue:8821

    Topics: Female; Humans; Nephrosis, Lipoid; Pefloxacin

1992